Go Pro

Procter & Gamble (PG) 10K Form and Latest SEC Filings 2026

Procter & Gamble logo
$145.54 -2.78 (-1.87%)
Closing price 03:59 PM Eastern
Extended Trading
$145.63 +0.09 (+0.06%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Latest Procter & Gamble SEC Filings & Recent Activity

Procter & Gamble (NYSE:PG) has submitted 1,690+ documents to the U.S. Securities and Exchange Commission (SEC) since 2017. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. Key figures from these filings, including revenue, earnings, and cash flow, are summarized in Procter & Gamble's financial statements. The most recent filing was a Form 11-K submitted on September 24, 2026.

Form 4
PROCTER & GAMBLE Co Reports Ownership Change on Sep. 17, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

10-Q
Procter & Gamble Files Quarterly Report on Apr. 24, 2026

The 10-Q contains Procter & Gamble's unaudited quarterly financial statements, revenue, earnings updates, and cash flow changes between annual reports.

View earnings history

Procter & Gamble SEC Filing History

Browse Procter & Gamble's complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
09/24/2026 2:45 PM
Procter & Gamble (80424) Filer
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
09/24/2026 12:24 PM
Procter & Gamble (80424) Filer
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
09/21/2026 1:16 PM
Procter & Gamble (80424) Filer
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
09/21/2026 1:16 PM
Procter & Gamble (80424) Filer
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
09/17/2026 12:41 PM
Aguilar Moses Victor Javier (1825382) Reporting
Procter & Gamble (80424) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2026 12:42 PM
Procter & Gamble (80424) Issuer
Santos de Azevedo Juliana Monteiro (2132273) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2026 12:43 PM
Jejurikar Shailesh (1746310) Reporting
Procter & Gamble (80424) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2026 12:45 PM
Procter & Gamble (80424) Issuer
Purushothaman Balaji (1957262) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2026 12:46 PM
Bharucha Freddy P. (2097043) Reporting
Procter & Gamble (80424) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2026 1:28 PM
ARNOLD CRAIG (1188578) Reporting
Procter & Gamble (80424) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2026 1:30 PM
JIMENEZ JOSEPH (1199095) Reporting
Procter & Gamble (80424) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2026 1:32 PM
Kempczinski Christopher J (1598115) Reporting
Procter & Gamble (80424) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2026 1:33 PM
McCarthy Christine M (1332169) Reporting
Procter & Gamble (80424) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2026 1:34 PM
McEvoy Ashley (1745936) Reporting
Procter & Gamble (80424) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2026 1:36 PM
Portman Robert Jones (1973769) Reporting
Procter & Gamble (80424) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/28/2026 6:00 AM
Procter & Gamble (80424) Filer
Form DEF 14A
08/28/2026 6:03 AM
Procter & Gamble (80424) Filer
Form DEFA14A
08/28/2026 6:05 AM
Procter & Gamble (80424) Filer
Form ARS
08/27/2026 1:23 PM
Aguilar Moses Victor Javier (1825382) Reporting
Procter & Gamble (80424) Issuer
Form 4/A
08/24/2026 3:34 PM
Janzaruk Matthew W. (1910008) Reporting
Procter & Gamble (80424) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2026 2:53 PM
Aguilar Moses Victor Javier (1825382) Reporting
Procter & Gamble (80424) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2026 2:36 PM
Jejurikar Shailesh (1746310) Reporting
Procter & Gamble (80424) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2026 2:38 PM
Procter & Gamble (80424) Issuer
Purushothaman Balaji (1957262) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2026 2:41 PM
Bharucha Freddy P. (2097043) Reporting
Procter & Gamble (80424) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2026 2:42 PM
Gama Paul (2110932) Reporting
Procter & Gamble (80424) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/24/2026 2:44 PM
Procter & Gamble (80424) Issuer
Schulten Andre (1844763) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2026 2:45 PM
Janzaruk Matthew W. (1910008) Reporting
Procter & Gamble (80424) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2026 2:46 PM
Procter & Gamble (80424) Issuer
Santos de Azevedo Juliana Monteiro (2132273) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2026 2:47 PM
Procter & Gamble (80424) Issuer
Raman Sundar G. (1882672) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2026 2:52 PM
Abd El Hak Hesham (2134647) Reporting
Procter & Gamble (80424) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2026 2:04 PM
Gama Paul (2110932) Reporting
Procter & Gamble (80424) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2026 11:40 AM
Pritchard Marc S. (1440364) Reporting
Procter & Gamble (80424) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2026 11:41 AM
Procter & Gamble (80424) Issuer
Whaley Susan Street (1929158) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2026 1:43 PM
Janzaruk Matthew W. (1910008) Reporting
Procter & Gamble (80424) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/21/2026 1:21 PM
Procter & Gamble (80424) Issuer
Purushothaman Balaji (1957262) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2026 1:25 PM
Procter & Gamble (80424) Issuer
Raman Sundar G. (1882672) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2026 1:26 PM
Procter & Gamble (80424) Issuer
Schulten Andre (1844763) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2026 1:27 PM
Procter & Gamble (80424) Issuer
Santos de Azevedo Juliana Monteiro (2132273) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2026 2:52 PM
Gama Paul (2110932) Reporting
Procter & Gamble (80424) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2026 2:57 PM
Janzaruk Matthew W. (1910008) Reporting
Procter & Gamble (80424) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2026 2:58 PM
Abd El Hak Hesham (2134647) Reporting
Procter & Gamble (80424) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
How options let you do more with less capital (Ad)

Would you rather spend $5,000 buying 100 shares of a $50 stock, or control those same 100 shares for a fraction of the cost? That's the core advantage options offer traders at every level. The Beginner's Guide to Options breaks down leverage, income strategies, and real trade examples in plain English — including a little-known approach many traders use to reduce costs and improve profit potential. Download your free copy before this offer expires.tc pixel

Claim your free copy of The Beginner's Guide to Options now
08/20/2026 2:59 PM
Aguilar Moses Victor Javier (1825382) Reporting
Procter & Gamble (80424) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2026 3:01 PM
Bharucha Freddy P. (2097043) Reporting
Procter & Gamble (80424) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2026 3:05 PM
Jejurikar Shailesh (1746310) Reporting
Procter & Gamble (80424) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2026 2:49 PM
Procter & Gamble (80424) Issuer
Whaley Susan Street (1929158) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2026 2:51 PM
Pritchard Marc S. (1440364) Reporting
Procter & Gamble (80424) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2026 9:53 AM
Procter & Gamble (80424) Subject
Schulten Andre (1844763) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/18/2026 9:54 AM
Procter & Gamble (80424) Subject
Purushothaman Balaji (1957262) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/18/2026 9:55 AM
Procter & Gamble (80424) Subject
Raman Sundar G. (1882672) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/18/2026 9:56 AM
Procter & Gamble (80424) Subject
Santos de Azevedo Juliana Monteiro (2132273) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/18/2026 9:39 AM
Gama Paul (2110932) Reporting
Procter & Gamble (80424) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/18/2026 9:41 AM
Abd El Hak Hesham (2134647) Reporting
Procter & Gamble (80424) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/18/2026 9:42 AM
Jejurikar Shailesh (1746310) Reporting
Procter & Gamble (80424) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/18/2026 9:43 AM
Janzaruk Matthew W. (1910008) Reporting
Procter & Gamble (80424) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/18/2026 9:45 AM
Moeller Jon R (1450613) Reporting
Procter & Gamble (80424) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/18/2026 9:46 AM
Pritchard Marc S. (1440364) Reporting
Procter & Gamble (80424) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/18/2026 9:48 AM
Procter & Gamble (80424) Subject
Whaley Susan Street (1929158) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/18/2026 9:36 AM
Aguilar Moses Victor Javier (1825382) Reporting
Procter & Gamble (80424) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/18/2026 9:37 AM
Bharucha Freddy P. (2097043) Reporting
Procter & Gamble (80424) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/10/2026 8:00 PM
Bharucha Freddy P. (2097043) Reporting
Procter & Gamble (80424) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2026 2:07 PM
Aguilar Moses Victor Javier (1825382) Reporting
Procter & Gamble (80424) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2026 2:09 PM
Abd El Hak Hesham (2134647) Reporting
Procter & Gamble (80424) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2026 2:18 PM
Jejurikar Shailesh (1746310) Reporting
Procter & Gamble (80424) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2026 11:23 AM
Procter & Gamble (80424) Issuer
Santos de Azevedo Juliana Monteiro (2132273) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2026 11:24 AM
Gama Paul (2110932) Reporting
Procter & Gamble (80424) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2026 11:13 AM
Moeller Jon R (1450613) Reporting
Procter & Gamble (80424) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2026 11:14 AM
Janzaruk Matthew W. (1910008) Reporting
Procter & Gamble (80424) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2026 11:16 AM
Pritchard Marc S. (1440364) Reporting
Procter & Gamble (80424) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2026 11:17 AM
Procter & Gamble (80424) Issuer
Purushothaman Balaji (1957262) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2026 11:19 AM
Procter & Gamble (80424) Issuer
Raman Sundar G. (1882672) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2026 11:20 AM
Procter & Gamble (80424) Issuer
Whaley Susan Street (1929158) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2026 11:21 AM
Procter & Gamble (80424) Issuer
Schulten Andre (1844763) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2026 3:11 PM
Procter & Gamble (80424) Subject
Whaley Susan Street (1929158) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/03/2026 8:42 AM
NEW YORK STOCK EXCHANGE LLC (876661) Filed by
Procter & Gamble (80424) Subject
Form 25-NSE
07/14/2026 3:19 PM
Procter & Gamble (80424) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2026 1:29 PM
Procter & Gamble (80424) Issuer
Santos de Azevedo Juliana Monteiro (2132273) Reporting
Form 3/A
07/10/2026 10:14 AM
Procter & Gamble (80424) Issuer
Santos de Azevedo Juliana Monteiro (2132273) Reporting
Form 3
Initial statement of beneficial ownership of securities  
06/10/2026 1:26 PM
McEvoy Ashley (1745936) Reporting
Procter & Gamble (80424) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2026 1:27 PM
Portman Robert Jones (1973769) Reporting
Procter & Gamble (80424) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2026 1:17 PM
ARNOLD CRAIG (1188578) Reporting
Procter & Gamble (80424) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2026 1:18 PM
JIMENEZ JOSEPH (1199095) Reporting
Procter & Gamble (80424) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2026 1:20 PM
Kempczinski Christopher J (1598115) Reporting
Procter & Gamble (80424) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2026 1:21 PM
McCarthy Christine M (1332169) Reporting
Procter & Gamble (80424) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2026 12:20 PM
Abd El Hak Hesham (2134647) Reporting
Procter & Gamble (80424) Issuer
Form 3
Initial statement of beneficial ownership of securities  
06/04/2026 12:58 PM
Procter & Gamble (80424) Filer
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
05/27/2026 9:11 AM
Procter & Gamble (80424) Filer
Form SD
Specialized Disclosure Report  
04/30/2026 11:10 AM
Procter & Gamble (80424) Subject
VANGUARD CAPITAL MANAGEMENT LLC (2100119) Filed by
Form SCHEDULE 13G
04/24/2026 3:14 PM
Procter & Gamble (80424) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/24/2026 9:02 AM
Procter & Gamble (80424) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2026 6:01 AM
Procter & Gamble (80424) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/14/2026 3:17 PM
Procter & Gamble (80424) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Should You Convert a Traditional IRA to a Roth After 60? (Ad)

Considering a Roth conversion after 60? The upside includes no income limits on conversions, potential tax-free qualified withdrawals, and no lifetime required minimum distributions. The catch: converting triggers ordinary income tax in the year you convert, and the decision cannot be reversed. The right move depends on your income, tax bracket, and retirement timeline.tc pixel

Take the free quiz to match with a vetted fiduciary advisor near you
04/07/2026 10:58 AM
Gama Paul (2110932) Reporting
Procter & Gamble (80424) Issuer
Form 3
Initial statement of beneficial ownership of securities  
03/27/2026 10:19 AM
Procter & Gamble (80424) Subject
VANGUARD GROUP INC (102909) Filed by
Form SCHEDULE 13G/A
03/19/2026 1:59 PM
Portman Robert Jones (1973769) Reporting
Procter & Gamble (80424) Issuer
Form 4/A
03/11/2026 1:01 PM
ARNOLD CRAIG (1188578) Reporting
Procter & Gamble (80424) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2026 1:03 PM
JIMENEZ JOSEPH (1199095) Reporting
Procter & Gamble (80424) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2026 1:04 PM
Kempczinski Christopher J (1598115) Reporting
Procter & Gamble (80424) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2026 1:05 PM
McCarthy Christine M (1332169) Reporting
Procter & Gamble (80424) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2026 1:06 PM
McEvoy Ashley (1745936) Reporting
Procter & Gamble (80424) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2026 1:07 PM
Portman Robert Jones (1973769) Reporting
Procter & Gamble (80424) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)

Procter & Gamble SEC Filings - Frequently Asked Questions

Procter & Gamble (PG) has submitted 1,690+ filings to the SEC since 2017. You can browse the complete history or filter by form type using the tools above.

Procter & Gamble's fiscal year ends on June 30. The company typically files its 10-K annual report by the end of August, covering the prior fiscal year's financial results. Key financial data from these reports is available on Procter & Gamble's financial statements page.

The most recent filing was a Form 11-K submitted on September 24, 2026. View the full filing using the link above.

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


SEC filings for NYSE:PG are sourced directly from the U.S. Securities and Exchange Commission (SEC), with the most recent filing dated 9/24/2026. New filings are added as they're published.
From Our Partners